SEARCH

SEARCH BY CITATION

References

  • 1
    Ehrlich P. Ueber die specifischen granulationen des Blutes. Arch Anat Physiol LPZ 1879;3: 571.
  • 2
    Adamko D, Lacy P, Moqbel R. Eosinophil function in allergic inflammation: from bone marrow to tissue response. Curr Allergy Asthma Rep 2004;4: 149158.
  • 3
    Butterworth AE, Vadas MA, Wassom DL, Dessein A, Hogan M, Sherry B et al. Interactions between human eosinophils and schistosomula of Schistosoma mansoni: II. The mechanism of irreversible eosinophil adherence. J Exp Med 1979;150: 14561471.
  • 4
    Butterworth AE, David JR. Eosinophil function. N Engl J Med 1981;304: 154156.
  • 5
    Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 1982;2: 1116.
  • 6
    Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986;77: 527537.
  • 7
    Wardlaw AJ, Moqbel R, Kay AB. Eosinophils: biology and role in disease. Adv Immunol 1995;60: 151266.
  • 8
    Clutterbuck E, Shields JG, Gordon J, Smith SH, Boyd A, Callard RE et al. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur J Immunol 1987;17: 17431750.
  • 9
    Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79: 31013109.
  • 10
    Egan RW, Athwahl D, Chou CC, Chapman RW, Emtage S, Jenh CH et al. Pulmonary biology of anti-interleukin 5 antibodies. Mem Inst Oswaldo Cruz 1997;92(Suppl. 2):6973.
  • 11
    Adamko D, Odemuyiwa SO, Moqbel R. The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning? Curr Opin Pharmacol 2003;3: 227232.
  • 12
    Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HA, Postma DS et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 2003;167: 16551659.
  • 13
    Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356: 21442148.
  • 14
    Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167: 199204.
  • 15
    Wilson SJ, Wallin A, Della-Cioppa G, Sandstrom T, Holgate ST. Effects of budesonide and formoterol on NF-kappa B, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med 2001;164: 10471052.
  • 16
    Nouri-Aria KT, Masuyama K, Jacobson MR, Rak S, Lowhagen O, Schotman E et al. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid. Int Arch Allergy Immunol 1998;117: 248254.
  • 17
    Liu LY, Sedgwick JB, Bates ME, Vrtis RF, Gern JE, Kita H et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol 2002;169: 64526458.
  • 18
    Liu LY, Sedgwick JB, Bates ME, Vrtis RF, Gern JE, Kita H et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J Immunol 2002;169: 64596466.
  • 19
    Denburg JA. Bone marrow in atopy and asthma: hematopoietic mechanisms in allergic inflammation. Immunol Today 1999;20: 111113.
  • 20
    Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A et al. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 1991;174: 749752.
  • 21
    Anwar AR, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 1993;177: 839843.
  • 22
    Levi-Schaffer F, Lacy P, Severs NJ, Newman TM, North J, Gomperts B et al. Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 1995;85: 25792586.
  • 23
    Moqbel R, Ying S, Barkans J, Newman TM, Kimmitt P, Wakelin M et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 1995;155: 49394947.
  • 24
    Woerly G, Lacy P, Younes AB, Roger N, Loiseau S, Moqbel R et al. Human eosinophils express and release IL-13 following CD28-dependent activation. J Leukoc Biol 2002;72: 769779.
  • 25
    Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002;169: 10211027.
  • 26
    Ying S, Meng Q, Taborda-Barata L, Corrigan CJ, Barkans J, Assoufi B et al. Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol 1996;26: 7076.
  • 27
    Foster PS, Mould AW, Yang M, Mackenzie J, Mattes J, Hogan SP et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 2001;179: 173181.
  • 28
    Cameron L, Christodoulopoulos P, Lavigne F, Nakamura Y, Eidelman D, McEuen A et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol 2000;164: 15381545.
  • 29
    Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158: 39023908.
  • 30
    Eidelman DH, Minshall E, Dandurand RJ, Schotman E, Song YL, Yasruel Z et al. Evidence for major basic protein immunoreactivity and interleukin 5 gene activation during the late phase response in explanted airways. Am J Respir Cell Mol Biol 1996;15: 582589.
  • 31
    Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 1998;188: 421429.
  • 32
    Shen HH, Ochkur SI, McGarry MP, Crosby JR, Hines EM, Borchers MT et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003;170: 32963305.
  • 33
    Denburg JA, Sehmi R, Saito H, Pil-Seob J, Inman MD, O'Byrne PM. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol 2000;106: S242S246.
  • 34
    Barnes PJ. Histamine and serotonin. Pulm Pharmacol Ther 2001;14: 329339.
  • 35
    Roffel AF, Elzinga CR, Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990;3: 4751.
  • 36
    Canning BJ, Reynolds SM, Mazzone SB. Multiple mechanisms of reflex bronchospasm in guinea pigs. J Appl Physiol 2001;91: 26422653.
  • 37
    Tulic MK, Wale JL, Petak F, Sly PD. Muscarinic blockade of methacholine induced airway and parenchymal lung responses in anaesthetised rats. Thorax 1999;54: 531537.
  • 38
    Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113: 131139.
  • 39
    Fryer AD, Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1984;83: 973978.
  • 40
    Minette PA, Barnes PJ. Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. J Appl Physiol 1988;64: 25322537.
  • 41
    Costello RW, Schofield BH, Kephart GM, Gleich GJ, Jacoby DB, Fryer AD. Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am J Physiol 1997;273: L93103.
  • 42
    Sawatzky DA, Kingham PJ, Durcan N, McLean WG, Costello RW. Eosinophil-induced release of acetylcholine from differentiated cholinergic nerve cells. Am J Physiol Lung Cell Mol Physiol 2003;285: L1296L1304.
  • 43
    Evans CM, Fryer AD, Jacoby DB, Gleich GJ, Costello RW. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest 1997;100: 22542262.
  • 44
    Adamko DJ, Yost BL, Gleich GJ, Fryer AD, Jacoby DB. Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, M2 muscarinic receptor dysfunction, and antiviral effects. J Exp Med 1999;190: 14651478.
  • 45
    Adamko DJ, Fryer AD, Bochner BS, Jacoby DB. CD8+ T lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction. Am J Respir Crit Care Med 2003;167: 550556.
  • 46
    Persson CG, Erjefalt JS. ‘Ultimate activation’ of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (CFEGs). Thorax 1997;52: 569574.
  • 47
    Erjefalt JS, Greiff L, Andersson M, Adelroth E, Jeffery PK, Persson CG. Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease. Thorax 2001;56: 341344.
  • 48
    Fryer AD, Yarkony KA, Jacoby DB. The effect of leukocyte depletion on pulmonary M2 muscarinic receptor function in parainfluenza virus-infected guinea-pigs. Br J Pharmacol 1994;112: 588594.
  • 49
    Makela MJ, Tripp R, Dakhama A, Park JW, Ikemura T, Joetham A et al. Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. J Allergy Clin Immunol 2003;112: 861869.
  • 50
    Kim CK, Kim SW, Park CS, Kim BI, Kang H, Koh YY. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol 2003;112: 6471.
  • 51
    Brooks GD, Buchta KA, Swenson CA, Gern JE, Busse WW. Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. Am J Respir Crit Care Med 2003;168: 10911094.
  • 52
    Jacoby DB, Xiao HQ, Lee NH, Chan-Li Y, Fryer AD. Virus- and interferon-induced loss of inhibitory M2 muscarinic receptor function and gene expression in cultured airway parasympathetic neurons. J Clin Invest 1998;102: 242248.
  • 53
    Persson CG, Erjefalt JS. Degranulation in eosinophils in human, but not in mouse, airways. Allergy 1999;54: 12301232.
  • 54
    Whitehead GS, Walker JK, Berman KG, Foster WM, Schwartz DA. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 2003;285: L32L42.
  • 55
    Lee NA, McGarry MP, Larson KA, Horton MA, Kristensen AB, Lee JJ. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol 1997;158: 13321344.
  • 56
    Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183: 195201.
  • 57
    Webb DC, McKenzie AN, Koskinen AM, Yang M, Mattes J, Foster PS. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 2000;165: 108113.
  • 58
    Kobayashi T, Iijima K, Kita H. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 2003;170: 57565763.
  • 59
    Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001;167: 46684675.
  • 60
    Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 2003;111: 677690.
  • 61
    Akiho H, Blennerhassett P, Deng Y, Collins SM. Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2002;282: G226G232.
  • 62
    Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002;26: 202208.
  • 63
    Mathur M, Herrmann K, Li X, Qin Y, Weinstock J, Elliott D et al. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am J Respir Crit Care Med 1999;159: 580587.
  • 64
    Foster PS, Webb DC, Yang M, Herbert C, Kumar RK. Dissociation of T helper type 2 cytokine-dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma. Clin Exp Allergy 2003;33: 688695.
  • 65
    Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9: 582588.
  • 66
    Bandeira-Melo C, Woods LJ, Phoofolo M, Weller PF. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med 2002;196: 841850.
  • 67
    Haczku A, Macary P, Haddad EB, Huang TJ, Kemeny DM, Moqbel R et al. Expression of Th-2 cytokines interleukin-4 and -5 and of Th-1 cytokine interferon-γ in ovalbumin-exposed sensitized Brown-Norway rats. Immunology 1996;88: 247251.
  • 68
    Velazquez JR, Lacy P, Mahmudi-Azer S, Bablitz B, Milne CD, Denburg JA et al. Interleukin-4 and RANTES expression in maturing eosinophils derived from human cord blood CD34+ progenitors. Immunology 2000;101: 419425.
  • 69
    Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F, Kay AB. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 2002;169: 46044612.
  • 70
    Celestin J, Rotschke O, Falk K, Ramesh N, Jabara H, Strominger J et al. IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils. J Immunol 2001;167: 60976104.
  • 71
    Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000;105: 945953.
  • 72
    MacKenzie JR, Mattes J, Dent LA, Foster PS. Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J Immunol 2001;167: 31463155.
  • 73
    van Rijt LS, Vos N, Hijdra D, de Vries VC, Hoogsteden HC, Lambrecht BN. Airway eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T cells. J Immunol 2003;171: 33723378.
  • 74
    Throsby M, Herbelin A, Pleau JM, Dardenne M. CD11c+ eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion. J Immunol 2000;165: 19651975.
  • 75
    Gharaee-Kermani M, Phan SH. The role of eosinophils in pulmonary fibrosis (Review). Int J Mol Med 1998;1: 4353.
  • 76
    Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2002;2: 4653.
  • 77
    Lacy P, Moqbel R. Eosinophil cytokines. Chem Immunol 2000;76: 134155.
  • 78
    Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 1995;181: 12111216.
  • 79
    Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002;9: 10691077.
  • 80
    Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, Capron M. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon γ): inhibition by immunoglobulin a complexes. J Exp Med 1999;190: 487495.
  • 81
    Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39: 177253.
  • 82
    Moqbel R, Lacy P. Eosinophils. In: DenburgJA, editor. Allergy and allergic diseases: the new mechanisms and therapeutics. Totowa, New Jersey: Humana Press, 1998: 139165.
  • 83
    Woodruff PG, Khashayar R, Lazarus SC, Janson S, Avila P, Boushey HA et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001;108: 753758.
  • 84
    O'Donnell RA, Frew AJ. Is there more than one inflammatory phenotype in asthma? Thorax 2002;57: 566568.
  • 85
    Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346: 16991705.
  • 86
    Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360: 17151721.
  • 87
    van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;164: 21072113.
  • 88
    Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154: 308317.
  • 89
    Jayaram L, Parameswaran K, Sears MR, Hargreave FE. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J 2000;16: 150158.
  • 90
    Mengelers HJ, Maikoe T, Brinkman L, Hooibrink B, Lammers JW, Koenderman L. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am J Respir Crit Care Med 1994;149: 345351.
  • 91
    Armstrong DS. In celebration of expectoration: induced sputum indices as outcome measures in cystic fibrosis. Am J Respir Crit Care Med 2003;168: 14121413.
  • 92
    Dorta RG, Landman G, Kowalski LP, Lauris JR, Latorre MR, Oliveira DT. Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas. Histopathology 2002;41: 152157.
  • 93
    Takanami I, Takeuchi K, Gika M. Immunohistochemical detection of eosinophilic infiltration in pulmonary adenocarcinoma. Anticancer Res 2002;22: 23912396.
  • 94
    Lorena SC, Oliveira DT, Dorta RG, Landman G, Kowalski LP. Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia. Oral Dis 2003;9: 279283.
  • 95
    Ascensao JL, Oken MM, Ewing SL, Goldberg RJ, Kaplan ME. Leukocytosis and large cell lung cancer. A frequent association. Cancer 1987;60: 903905.
  • 96
    Agarwal S, Wadhwa N, Gupta G. Eosinophils as a marker for invasion in cervical squamous neoplastic lesions. Int J Gynecol Pathol 2003;22: 213.
  • 97
    Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis 1993;148: S126.
  • 98
    Plotz SG, Simon HU, Darsow U, Simon D, Vassina E, Yousefi S et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 2003;349: 23342339.
  • 99
    Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK et al. Anti-interleukin-5 (Mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004;113: 115119.